FIELD: medicine.
SUBSTANCE: method involves administering Aevit, Unidox as a background therapy of degree I and II, and Isotretinoin and Cynovit gel as a background therapy of degree III and IV. Besides, Magnerot® 3.0 g is taken once a day (1.0 g three times a day) throughout the all background therapy.
EFFECT: invention enables providing higher clinical effectiveness in the patients with acne and connective tissue dysplasia.
1 tbl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF AGE-SPECIFIC THERAPY AND PREVENTION OF CONNECTIVE TISSUE DYSPLASIA | 2016 |
|
RU2657751C1 |
| DIAGNOSTIC TECHNIQUE FOR CONNECTIVE TISSUE DYSPLASIA | 2009 |
|
RU2400137C1 |
| METHOD FOR PREDICTING THE RISK OF SEVERE ACNE BASED ON MEFV GENE EXPRESSION | 2020 |
|
RU2746115C1 |
| SOLUTION FOR TREATMENT OF SKIN SICKNESS, METHOD OF ITS PREPARING AND METHOD OF SKIN SICKNESS TREATMENT | 2002 |
|
RU2197235C1 |
| METHOD OF TREATING MODERATE ACNE | 2010 |
|
RU2425682C1 |
| METHOD FOR PREVENTIVE DIFFERENTIATED TREATMENT OF INDIVIDUALS BEING IN CONTACT WITH PATIENTS SUFFERING INFECTIOUS STAGE OF SYPHILIS | 2012 |
|
RU2488400C1 |
| METHOD FOR PREDICTION OF UNFAVOURABLE CLINICAL COURSE OF NONSPECIFIC VULVOVAGINITIS IN GIRLS | 2011 |
|
RU2482484C2 |
| AGE-SPECIFIC DIAGNOSTIC TECHNIQUE FOR VARIOUS FORMS OF CONNECTIVE TISSUE DYSPLASIA SYNDROME | 2013 |
|
RU2543166C2 |
| METHOD OF PREVENTIVE THERAPY OF CHILDREN WHO HAD IN CLOSE DOMESTIC CONTACT WITH PATIENTS SUFFERING INFECTIOUS STAGE OF SYPHILIS | 2011 |
|
RU2487715C1 |
| METHOD OF TREATMENT OF ROSACEA | 2020 |
|
RU2811956C2 |
